Author Summary
Pre-Treatment Pan-Immune-Inflammation Value Predicts Prognosis in Limited-Stage Small-Cell Lung Cancer
Clinical Background Small-cell lung cancer (SCLC) accounts for about 15 % of all lung cancers and is one of the most aggressive types because it grows rapidly and spreads early. It is classified as limited […]